SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 254 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.03 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $822,689 | -6.7% | 29,840 | +1.7% | 0.46% | -2.3% |
| Q2 2023 | $881,960 | -20.8% | 29,340 | -4.6% | 0.47% | -23.1% |
| Q1 2023 | $1,113,710 | +1.6% | 30,740 | 0.0% | 0.62% | -1.3% |
| Q4 2022 | $1,096,496 | +5.1% | 30,740 | -0.3% | 0.62% | -6.7% |
| Q3 2022 | $1,043,000 | +10.7% | 30,840 | -5.4% | 0.67% | +16.4% |
| Q2 2022 | $942,000 | -11.9% | 32,590 | -1.5% | 0.57% | -0.2% |
| Q1 2022 | $1,069,000 | +14.3% | 33,090 | +3.1% | 0.58% | +30.1% |
| Q4 2021 | $935,000 | – | 32,090 | – | 0.44% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ASHFORD CAPITAL MANAGEMENT INC | 699,432 | $35,216,000 | 4.25% |
| Provident Investment Management, Inc. | 590,269 | $29,720,000 | 4.23% |
| CAPITAL MANAGEMENT CORP /VA | 225,232 | $11,340,000 | 2.90% |
| FALCON POINT CAPITAL, LLC | 188,341 | $9,483,000 | 2.04% |
| Ranger Investment Management | 600,464 | $30,233,000 | 2.00% |
| NEUMEIER POMA INVESTMENT COUNSEL LLC | 471,260 | $23,728,000 | 1.96% |
| KOPP INVESTMENT ADVISORS LLC | 41,700 | $2,100,000 | 1.77% |
| SHAKER INVESTMENTS LLC/OH | 49,617 | $2,498,000 | 1.54% |
| Bruce & Co., Inc. | 148,058 | $7,454,000 | 1.44% |
| Bridge City Capital, LLC | 45,843 | $2,308,000 | 1.43% |